Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

April 18, 2021

Bioengineered microfluidic blood-brain barrier models in oncology research.

Translational Oncology
Robin AugustineAnwarul Hasan
April 16, 2021

Measuring barrier function in organ-on-chips with cleanroom-free integration of multiplexable electrodes.

Lab on a Chip
Elsbeth G B M BossinkLoes I Segerink
April 16, 2021

High altitude cerebral edema - its own entity or end-stage acute mountain sickness?

Journal of Applied Physiology
Rachel E F TurnerJustin Stevan Lawley
April 16, 2021
Open Access

Examination of a blood-brain barrier targeting β-galactosidase-monoclonal antibody fusion protein in a murine model of GM1-gangliosidosis.

Molecular Genetics and Metabolism Reports
Michael J PrzybillaChester B Whitley
April 15, 2021

Dietary spermidine improves cognitive function.

Cell Reports
Sabrina SchroederFrank Madeo
April 15, 2021
Open Access

Cryopreservation of human cerebral microvascular endothelial cells and astrocytes in suspension and monolayers.

PloS One
Leah A Marquez-CurtisJanet A W Elliott
April 15, 2021

Exercise alleviates symptoms of CNS lupus.

Brain Research
Alexander JacobJessy Alexander
April 14, 2021

Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment.

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Zahra AsefyZaker Ceferov
April 14, 2021

An engineered neurovascular unit for modeling neuroinflammation.

Suyeong SeoHong Nam Kim
April 13, 2021

Small Interfering RNA Targeting DMP1 Protects Mice Against Blood-Brain Barrier Disruption and Brain Injury After Intracerebral Hemorrhage.

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Yue ShuWeitian Lu
April 12, 2021
Open Access

Isolation of sensory hair cell specific exosomes in human perilymph

BioRxiv : the Preprint Server for Biology
Z. PeiHinrich Staecker
April 12, 2021

miR-24 targets HMOX1 to regulate inflammation and neurofunction in rats with cerebral vasospasm after subarachnoid hemorrhage.

American Journal of Translational Research
Xiaodong DengQi Zhang
April 12, 2021
Open Access

Glial Cell-Based Vascular Mechanisms and Transplantation Therapies in Brain Vessel and Neurodegenerative Diseases.

Frontiers in Cellular Neuroscience
Yingying ZhaoZheng Zachory Wei

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved